TY - JOUR
T1 - Lamivudine in the treatment of acute hepatitis B [3]
AU - Reshef, Ron
AU - Sbeit, Wisam
AU - Tur-Kaspa, Ran
PY - 2000/10/12
Y1 - 2000/10/12
N2 - To the Editor: Lamivudine, a nucleoside analogue, has shown promising results in the treatment of hepatitis B virus (HBV) infection through its inhibitory action on reverse-transcriptase activity.1,2 Lamivudine has been used to treat acute hepatitis B after liver transplantation and heart transplantation, and there are now preliminary results from a multicenter trial of its use after liver transplantation.3,4 We report the use of lamivudine in a 74-year-old woman with acute hepatitis B. The patient was admitted because of acute hepatitis B of two months' duration. Physical examination revealed a well-nourished, conscious woman with mild jaundice but otherwise normal . . .
AB - To the Editor: Lamivudine, a nucleoside analogue, has shown promising results in the treatment of hepatitis B virus (HBV) infection through its inhibitory action on reverse-transcriptase activity.1,2 Lamivudine has been used to treat acute hepatitis B after liver transplantation and heart transplantation, and there are now preliminary results from a multicenter trial of its use after liver transplantation.3,4 We report the use of lamivudine in a 74-year-old woman with acute hepatitis B. The patient was admitted because of acute hepatitis B of two months' duration. Physical examination revealed a well-nourished, conscious woman with mild jaundice but otherwise normal . . .
UR - http://www.scopus.com/inward/record.url?scp=0034642049&partnerID=8YFLogxK
U2 - 10.1056/NEJM200010123431513
DO - 10.1056/NEJM200010123431513
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???
C2 - 11032526
AN - SCOPUS:0034642049
SN - 0028-4793
VL - 343
SP - 1123
EP - 1124
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 15
ER -
